Delivery of new anti-malaria drugs to developing countries is vital in fight against the disease

Posted 5th May 2015

David Reddy, Medicines for Malaria Venture’s chief executive officer, discusses developments in the fight against the disease ahead of World Malaria Day on 25 April. Medicines for Malaria Venture (MMV), a public-private partnership that seeks to develop and facilitate the delivery of quality anti-malaria drugs at affordable prices to people in developing countries.